Oshrat Levi
@Sphera Funds Management Ltd.
Latest period2024 - Q3ReportedManaged Assets$628.383MTotal holdings109
Assets growth rate-14.3%Assets growth rate (2-Q avg)-5.64%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Sphera Funds Management Ltd.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 109 positions.
Assets under management
The assets under management (AUM) of Sphera Funds Management Ltd. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 628.383M in assets, with a quarterly growth rate of -14.3% and a 2-quarter average growth rate of -5.64%. The portfolio is managed by Oshrat Levi, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
TEVATeva Pharmaceutical Inds Ltd
| 6.11% | $38.386M 2.13M shares@ $18.02 avg price | Decreased -47.5% |
SNYSanofi
| 3.76% | $23.6M 409,515 shares@ $57.63 avg price | Decreased -8.89% |
BBIOBridgebio Pharma Inc
| 3.42% | $21.454M 842,644 shares@ $25.46 avg price | Decreased -24.4% |
NICENice Ltd
| 3.06% | $19.184M 110,461 shares@ $173.68 avg price | Decreased -2.72% |
METAMeta Platforms Inc
| 2.68% | $16.782M 29,316 shares@ $572.44 avg price | Decreased -12.32% |
CYTKCytokinetics Inc
| 2.32% | $14.521M 275,021 shares@ $52.81 avg price | Decreased -28.55% |
AAPLApple Inc
| 2.26% | $14.177M 60,847 shares@ $233.0 avg price | Decreased -1.06% |
PRAXPraxis Precision Medicines I
| 2.24% | $14.057M 244,307 shares@ $57.55 avg price | Decreased -31.83% |
KURAKura Oncology Inc
| 1.9% | $11.921M 610,087 shares@ $19.55 avg price | Decreased -0.12% |
RAREUltragenyx Pharmaceutical In
| 1.73% | $10.852M 195,349 shares@ $55.56 avg price | Decreased -33.51% |